Dasatinib and disease progression 
Dasatinib and disease progression Patient Reports February 11, 2012
Dasatinib Side Effects Report #5845066-7
Dasatinib side effect was reported by a Health Professional from UNITED STATES on Aug 13, 2008. Male patient, weighting 219.4 lb, was diagnosed with sarcoma and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: abdominal pain
, constipation , dehydration, disease progression, metastases to central nervous system, metastasis, pericardial effusion, pleural effusion. Dasatinib dosage: 70 MG BID PO. Patient was hospitalized. Patient recovered.Dasatinib Side Effects Report #5826598-4
Dasatinib side effect was reported by a Physician from UNITED STATES on July 28, 2008. Male patient, weighting 192.5 lb, was diagnosed with prostate cancer
and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, disease progression, hyponatraemia, nausea , pain . Dasatinib dosage: 70 MG BID, PO. During the same period patient was treated with ENTERIC ASPIRIN, DOCUSATE, PREDNISONE, METOPROLOL SUCCINATE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, METFORMIN, PROCHLORPERAZINE, MORPHINE. Patient died on 07/25/2008.Dasatinib Side Effects Report #5826831-9
Dasatinib side effect was reported by a Physician from UNITED STATES on July 29, 2008. Male patient, weighting 192.5 lb, was diagnosed with prostate cancer
and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, disease progression, hyponatraemia, incorrect dose administered, nausea , pain . Dasatinib dosage: 70 MG BID, PO. During the same period patient was treated with ENTERIC ASPIRIN, DOCUSATE, PREDNISONE, METOPROLOL SUCCINATE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, METFORMIN, PROCHLORPERAZINE, MORPHINE. Patient died on 07/24/2008.Dasatinib Side Effects Report #5744206-8
Dasatinib side effect was reported by a Health Professional from UNITED STATES on May 15, 2008. Male patient, weighting 223.0 lb, was diagnosed with neoplasm malignant and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: disease progression, hypoxia, pleural effusion, small intestinal obstruction. Dasatinib dosage: 150MG DAILY PO. During the same period patient was treated with CETUXIMAB, THYROID, CENTRUM, ALLIEVE, NORVASC, VITAMIN D, ASPIRIN, DIOVAN. Patient was hospitalized. Patient recovered.
Dasatinib Side Effects Report #6008891-8
Dasatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 17, 2008. Male patient, weighting 415.8 lb, was diagnosed with malignant melanoma and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: ascites, constipation
, disease progression, lymphoedema, pleural effusion, white blood cell count increased. Dasatinib dosage: 50 MG 2 X DAILY. During the same period patient was treated with DACARBAZINE, HYDROCODONE, ZOFRAN, COMPAZINE, FENTANYL, DULCOLAX, SENOKOT. Patient was hospitalized. Patient recovered.Dasatinib Side Effects Report #5947964-2
Dasatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 10, 2008. Male patient, 62 years of age, weighting 156.7 lb, was diagnosed with glioblastoma multiforme and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: asthenia, convulsion, dehydration, disease progression, dizziness
, fall , hypotension, hypovolaemia, pyrexia. Dasatinib dosage: 210 MG DAILY PO. During the same period patient was treated with ERLOTINIB, COREG, LIPITOR, LISINOPRIL, DONNATAL, DEPAKOTE. Patient was hospitalized. Patient recovered.Dasatinib Side Effects Report #5955171-2
Dasatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 13, 2008. Male patient, 62 years of age, weighting 156.7 lb, was diagnosed with glioblastoma multiforme and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: asthenia, convulsion, dehydration, disease progression, dizziness
, fall , hypotension, hypovolaemia, pyrexia. Dasatinib dosage: 210 MG DAILY PO. During the same period patient was treated with ERLOTINIB, COREG, LIPITOR, LISINOPRIL AND HYDROCHLOROTHIAZIDE, DONNATAL, DEPAKOTE. Patient was hospitalized. Patient recovered.Dasatinib Side Effects Report #5743622-8
Dasatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 19, 2008. Male patient, weighting 185.8 lb, was diagnosed with glioblastoma and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: aphasia
, ataxia , confusional state, disease progression. Dasatinib dosage: 100MG DAYS 1-28 PO DAILY. During the same period patient was treated with ERLOTINIB GENENTECH, DILANTIN, KEPPRA, BENADRYL, LEVAQUIN, SENOKOT. Patient was hospitalized. Patient recovered.Dasatinib Side Effects Report #5972575-2
Dasatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 26, 2008. Male patient, weighting 199.1 lb, was diagnosed with glioblastoma and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: disease progression, headache
, hemiparesis, ileus, lethargy, mental status changes, neuropathy peripheral. Dasatinib dosage: 180MG DAYS 1-28 PO DAILY. During the same period patient was treated with ERLOTINIB GENENTECH, DEXAMETHASONE, GLYBURIDE, LASIX, METFORMIN, DARVOCET. Patient was hospitalized. Patient recovered.Dasatinib Side Effects Report #5880015-7
Dasatinib side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2008. Male patient, weighting 229.3 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, fatigue, gastritis, gastrooesophageal reflux disease, metastases to liver, metastases to lung, metastases to peritoneum. Dasatinib dosage: 100 MG DAILY PO. Patient died on 09/04/2008.
Dasatinib Side Effects Report #5892953-X
Dasatinib side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2008. Female patient, 57 years of age, weighting 142.6 lb, was diagnosed with breast cancer metastatic and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: clostridial infection, colitis, disease progression. Dasatinib dosage: 70 MG BID PO. During the same period patient was treated with MVI CENTRUM SILVER, GLUCOSAMINE, CALCIUM GLUCONATE, MYCO SOFT GOLD MUSHROOM SUPPLEMENT, OXYCODONE, OXYCONTIN, ZOFRAN, IBUPROFEN. Patient was hospitalized. Patient recovered.
Dasatinib Side Effects Report #5910154-3
Dasatinib side effect was reported by a Health Professional from UNITED KINGDOM on Sept 29, 2008. Male patient, 67 years of age, weighting 169.8 lb, was treated with Dasatinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, platelet count increased, skin reaction. Dasatinib dosage: unknown. During the same period patient was treated with IMATINIB MESILATE, AMITRIPTYLINE, ATENOLOL, ACETAMINOPHEN W, MS CONTIN, WARFARIN. Patient recovered.
Dasatinib Side Effects Report #5913240-7
Dasatinib side effect was reported by a Health Professional from UNITED KINGDOM on Oct 08, 2008. Male patient, 67 years of age, weighting 169.8 lb, was treated with Dasatinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, platelet count increased, skin reaction. Dasatinib dosage: unknown. During the same period patient was treated with IMATINIB MESILATE, AMITRIPTYLINE, ATENOLOL, ACETAMINOPHEN W, MS CONTIN, WARFARIN. Patient recovered.
Dasatinib Side Effects Report #5420880-0
Dasatinib side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2007. Female patient, weighting 167.3 lb, was treated with Dasatinib. After drug was administered, patient experienced the following side effects: dehydration, disease progression, headache
, hypercalcaemia, lethargy, metastases to central nervous system, visual disturbance. Dasatinib dosage: 100MG QDAY PO. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.